Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ets1
|
ENSMUSG00000032035.9 | E26 avian leukemia oncogene 1, 5' domain |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr9_32685725_32686117 | Ets1 | 10101 | 0.179029 | -0.68 | 1.1e-08 | Click! |
chr9_32686274_32686469 | Ets1 | 9651 | 0.180183 | -0.65 | 6.4e-08 | Click! |
chr9_32675770_32676060 | Ets1 | 20107 | 0.157010 | -0.64 | 1.3e-07 | Click! |
chr9_32685494_32685645 | Ets1 | 10453 | 0.178164 | -0.60 | 1.1e-06 | Click! |
chr9_32668243_32668394 | Ets1 | 27704 | 0.138882 | -0.53 | 3.0e-05 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_14354416_14355184 | 50.99 |
Il3ra |
interleukin 3 receptor, alpha chain |
5179 |
0.12 |
chrX_123721926_123722462 | 31.06 |
Rps12-ps23 |
ribosomal protein S12, pseudogene 23 |
13617 |
0.18 |
chrX_123943434_123943951 | 31.05 |
Rps12-ps20 |
ribosomal protein S12, pseudogene 20 |
13582 |
0.23 |
chrX_123271195_123271712 | 30.20 |
Rps12-ps21 |
ribosomal protein S12, pseudogene 22 |
13591 |
0.15 |
chrX_123500550_123501093 | 29.56 |
Rps12-ps22 |
ribosomal protein S12, pseudogene 22 |
13606 |
0.18 |
chr8_25969482_25969806 | 21.73 |
Hgsnat |
heparan-alpha-glucosaminide N-acetyltransferase |
2584 |
0.2 |
chr11_32542782_32542963 | 21.47 |
Stk10 |
serine/threonine kinase 10 |
9567 |
0.2 |
chr3_146655388_146655585 | 19.65 |
4930503B20Rik |
RIKEN cDNA 4930503B20 gene |
4169 |
0.15 |
chr5_116029123_116029309 | 18.81 |
Gm13842 |
predicted gene 13842 |
14 |
0.96 |
chr7_127091121_127091448 | 18.20 |
AI467606 |
expressed sequence AI467606 |
75 |
0.92 |
chr11_98941353_98942362 | 16.57 |
Rara |
retinoic acid receptor, alpha |
2145 |
0.18 |
chr1_36919717_36920078 | 15.46 |
Gm38115 |
predicted gene, 38115 |
3358 |
0.17 |
chr3_87901211_87901576 | 15.29 |
Hdgf |
heparin binding growth factor |
4928 |
0.11 |
chr9_32400635_32401003 | 15.16 |
Kcnj1 |
potassium inwardly-rectifying channel, subfamily J, member 1 |
6834 |
0.18 |
chr8_84197696_84198961 | 14.74 |
Gm26887 |
predicted gene, 26887 |
661 |
0.38 |
chr19_32272552_32272859 | 14.44 |
Sgms1 |
sphingomyelin synthase 1 |
4221 |
0.28 |
chr8_85380799_85381247 | 14.06 |
Mylk3 |
myosin light chain kinase 3 |
11 |
0.97 |
chr11_5575195_5575383 | 13.98 |
Ankrd36 |
ankyrin repeat domain 36 |
1206 |
0.39 |
chr2_157027719_157028058 | 13.92 |
Soga1 |
suppressor of glucose, autophagy associated 1 |
416 |
0.77 |
chr2_84810833_84811663 | 13.87 |
Ube2l6 |
ubiquitin-conjugating enzyme E2L 6 |
5019 |
0.11 |
chr2_3657823_3658259 | 13.80 |
Gm13183 |
predicted gene 13183 |
22549 |
0.15 |
chr1_131638169_131638320 | 13.63 |
Ctse |
cathepsin E |
62 |
0.97 |
chr17_48300944_48301125 | 13.38 |
Treml2 |
triggering receptor expressed on myeloid cells-like 2 |
648 |
0.59 |
chr10_21269157_21269345 | 13.04 |
Gm33728 |
predicted gene, 33728 |
17137 |
0.14 |
chr1_151198225_151198491 | 12.61 |
Gm47995 |
predicted gene, 47995 |
90 |
0.94 |
chr8_123797895_123798249 | 12.56 |
Rab4a |
RAB4A, member RAS oncogene family |
7913 |
0.09 |
chr4_135312755_135313155 | 12.46 |
Gm12982 |
predicted gene 12982 |
4985 |
0.13 |
chr11_87751706_87751911 | 12.44 |
Mir142hg |
Mir142 host gene (non-protein coding) |
3769 |
0.1 |
chr10_43593614_43593879 | 12.28 |
F930017D23Rik |
RIKEN cDNA F930017D23 gene |
307 |
0.86 |
chr17_47909349_47909983 | 12.27 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr16_32130295_32130491 | 12.22 |
Nrros |
negative regulator of reactive oxygen species |
17488 |
0.1 |
chr10_118064868_118065238 | 12.17 |
5330439M10Rik |
RIKEN cDNA 5330439M10 gene |
47464 |
0.11 |
chr9_71606817_71607016 | 12.04 |
Gm6018 |
predicted gene 6018 |
6776 |
0.19 |
chr13_96697933_96698100 | 11.99 |
Gm48575 |
predicted gene, 48575 |
19893 |
0.14 |
chr19_47432341_47432749 | 11.91 |
Sh3pxd2a |
SH3 and PX domains 2A |
22186 |
0.18 |
chr5_118483047_118483221 | 11.89 |
Gm15754 |
predicted gene 15754 |
3833 |
0.24 |
chr15_36580548_36581460 | 11.85 |
Gm44310 |
predicted gene, 44310 |
2540 |
0.2 |
chr14_21032131_21032511 | 11.78 |
Vcl |
vinculin |
10318 |
0.18 |
chr8_70609185_70610414 | 11.76 |
Gm45546 |
predicted gene 45546 |
626 |
0.42 |
chr18_12166800_12167170 | 11.61 |
Rmc1 |
regulator of MON1-CCZ1 |
1732 |
0.26 |
chr13_100866324_100866684 | 11.57 |
Gm37830 |
predicted gene, 37830 |
6276 |
0.15 |
chr8_88288889_88289304 | 11.45 |
Adcy7 |
adenylate cyclase 7 |
51 |
0.98 |
chr9_65217162_65217313 | 11.44 |
Parp16 |
poly (ADP-ribose) polymerase family, member 16 |
2083 |
0.21 |
chr5_117138594_117138824 | 11.42 |
Taok3 |
TAO kinase 3 |
5068 |
0.16 |
chr1_91301585_91301867 | 11.42 |
Scly |
selenocysteine lyase |
1071 |
0.36 |
chr1_86479174_86479713 | 11.15 |
Rpl30-ps6 |
ribosomal protein L30, pseudogene 6 |
5784 |
0.15 |
chr8_14012666_14012842 | 11.02 |
Gm5907 |
predicted gene 5907 |
13814 |
0.15 |
chr4_115075617_115075815 | 11.00 |
Pdzk1ip1 |
PDZK1 interacting protein 1 |
12992 |
0.14 |
chr8_25969827_25970012 | 10.92 |
Hgsnat |
heparan-alpha-glucosaminide N-acetyltransferase |
2309 |
0.21 |
chr1_80218340_80218558 | 10.84 |
Fam124b |
family with sequence similarity 124, member B |
24 |
0.97 |
chr2_120128702_120129052 | 10.73 |
Ehd4 |
EH-domain containing 4 |
848 |
0.58 |
chr2_121036499_121036885 | 10.71 |
Epb42 |
erythrocyte membrane protein band 4.2 |
11 |
0.96 |
chr2_153492229_153493481 | 10.71 |
4930404H24Rik |
RIKEN cDNA 4930404H24 gene |
65 |
0.82 |
chr8_122547810_122548264 | 10.68 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
3292 |
0.12 |
chr19_53080891_53081464 | 10.62 |
1700054A03Rik |
RIKEN cDNA 1700054A03 gene |
400 |
0.83 |
chr11_121559670_121559821 | 10.57 |
Tbcd |
tubulin-specific chaperone d |
9634 |
0.2 |
chr9_60280023_60280252 | 10.53 |
2010001M07Rik |
RIKEN cDNA 2010001M07 gene |
54005 |
0.14 |
chr10_62327332_62327499 | 10.52 |
Hk1 |
hexokinase 1 |
352 |
0.86 |
chr7_127218383_127218616 | 10.40 |
Septin1 |
septin 1 |
1 |
0.93 |
chr8_84979246_84980613 | 10.27 |
Junb |
jun B proto-oncogene |
1211 |
0.19 |
chr1_151182389_151182658 | 10.21 |
Gm47985 |
predicted gene, 47985 |
14 |
0.96 |
chr15_99449170_99449742 | 10.18 |
Nckap5l |
NCK-associated protein 5-like |
8256 |
0.1 |
chr17_26535257_26535653 | 10.08 |
Gm50275 |
predicted gene, 50275 |
2772 |
0.15 |
chr1_87626506_87626684 | 10.06 |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
4921 |
0.19 |
chr4_115850014_115850176 | 10.04 |
Mknk1 |
MAP kinase-interacting serine/threonine kinase 1 |
6937 |
0.13 |
chr1_151192192_151192482 | 9.94 |
Gm8947 |
predicted gene 8947 |
39 |
0.96 |
chr17_31224059_31224210 | 9.94 |
Ubash3a |
ubiquitin associated and SH3 domain containing, A |
4533 |
0.14 |
chr8_122323502_122324203 | 9.81 |
Zfpm1 |
zinc finger protein, multitype 1 |
9846 |
0.13 |
chr12_13145384_13145901 | 9.79 |
Rpl21-ps2 |
ribosomal protein L21, pseudogene 2 |
4518 |
0.18 |
chr4_145200648_145200824 | 9.76 |
Vps13d |
vacuolar protein sorting 13D |
5731 |
0.24 |
chr7_142381361_142381512 | 9.75 |
Gm49369 |
predicted gene, 49369 |
572 |
0.59 |
chr6_72389979_72390703 | 9.69 |
Vamp8 |
vesicle-associated membrane protein 8 |
362 |
0.76 |
chr15_77800538_77800855 | 9.69 |
Myh9 |
myosin, heavy polypeptide 9, non-muscle |
12535 |
0.13 |
chr10_62506208_62506533 | 9.67 |
Srgn |
serglycin |
1385 |
0.34 |
chr14_16173434_16173602 | 9.64 |
Gm8517 |
predicted gene 8517 |
2121 |
0.31 |
chr2_170147589_170148059 | 9.63 |
Zfp217 |
zinc finger protein 217 |
279 |
0.95 |
chr1_151209939_151210232 | 9.61 |
Gm47996 |
predicted gene, 47996 |
46 |
0.96 |
chr10_77531384_77531539 | 9.54 |
Itgb2 |
integrin beta 2 |
1081 |
0.41 |
chr16_11006092_11006292 | 9.47 |
Gm24961 |
predicted gene, 24961 |
11806 |
0.1 |
chr8_68606713_68606995 | 9.45 |
Gm15654 |
predicted gene 15654 |
13284 |
0.25 |
chr4_127263680_127264160 | 9.41 |
Smim12 |
small integral membrane protein 12 |
20136 |
0.12 |
chr9_57300915_57301066 | 9.40 |
Gm18996 |
predicted gene, 18996 |
28425 |
0.12 |
chr11_116506385_116506879 | 9.38 |
Rpl36-ps1 |
ribosomal protein L36, pseudogene 1 |
2096 |
0.17 |
chr2_26578486_26578697 | 9.30 |
Egfl7 |
EGF-like domain 7 |
1423 |
0.23 |
chr11_57445340_57445511 | 9.29 |
Gm12242 |
predicted gene 12242 |
3682 |
0.29 |
chr9_32901255_32901639 | 9.23 |
Gm27162 |
predicted gene 27162 |
27519 |
0.18 |
chr11_78772009_78772185 | 9.20 |
Gm23840 |
predicted gene, 23840 |
17575 |
0.14 |
chr17_87299012_87299237 | 9.13 |
Ttc7 |
tetratricopeptide repeat domain 7 |
6313 |
0.15 |
chr2_29944653_29945057 | 9.12 |
Gle1 |
GLE1 RNA export mediator (yeast) |
2130 |
0.19 |
chr4_132605981_132606142 | 9.11 |
Eya3 |
EYA transcriptional coactivator and phosphatase 3 |
32926 |
0.1 |
chr19_56264265_56264546 | 9.10 |
Gm22271 |
predicted gene, 22271 |
13240 |
0.2 |
chr11_64801456_64801643 | 9.08 |
Gm12291 |
predicted gene 12291 |
41522 |
0.17 |
chr4_155075802_155075953 | 9.07 |
Pex10 |
peroxisomal biogenesis factor 10 |
8818 |
0.12 |
chr11_53795189_53795552 | 9.04 |
Gm12216 |
predicted gene 12216 |
505 |
0.69 |
chr18_50028238_50028565 | 9.04 |
Tnfaip8 |
tumor necrosis factor, alpha-induced protein 8 |
2617 |
0.3 |
chr2_103896151_103896680 | 9.01 |
Gm13876 |
predicted gene 13876 |
8091 |
0.12 |
chr2_4559355_4560175 | 9.00 |
Frmd4a |
FERM domain containing 4A |
9 |
0.98 |
chr1_151203937_151204219 | 8.99 |
3110040M04Rik |
RIKEN cDNA 3110040M04 gene |
43 |
0.96 |
chr5_142920749_142921092 | 8.98 |
Actb |
actin, beta |
14166 |
0.14 |
chr11_88068171_88069196 | 8.93 |
Vezf1 |
vascular endothelial zinc finger 1 |
404 |
0.76 |
chr19_5661429_5661792 | 8.93 |
Sipa1 |
signal-induced proliferation associated gene 1 |
25 |
0.93 |
chr6_60934969_60935379 | 8.91 |
Mmrn1 |
multimerin 1 |
9302 |
0.22 |
chr5_117133502_117133674 | 8.91 |
Taok3 |
TAO kinase 3 |
0 |
0.97 |
chr9_63043485_63043636 | 8.89 |
Gm24526 |
predicted gene, 24526 |
16000 |
0.17 |
chr14_14351950_14353283 | 8.85 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr16_38362984_38363227 | 8.84 |
Popdc2 |
popeye domain containing 2 |
860 |
0.48 |
chr11_51016438_51016589 | 8.82 |
Olfr54 |
olfactory receptor 54 |
2156 |
0.16 |
chr11_53518889_53519045 | 8.82 |
Septin8 |
septin 8 |
290 |
0.82 |
chr19_37561646_37561845 | 8.77 |
Exoc6 |
exocyst complex component 6 |
11286 |
0.21 |
chr10_93069420_93069622 | 8.75 |
Cfap54 |
cilia and flagella associated protein 54 |
730 |
0.7 |
chr13_106893317_106893509 | 8.72 |
Ipo11 |
importin 11 |
31737 |
0.12 |
chr15_6520395_6520755 | 8.64 |
Fyb |
FYN binding protein |
2278 |
0.34 |
chr5_146230632_146231967 | 8.63 |
Cdk8 |
cyclin-dependent kinase 8 |
11 |
0.96 |
chr1_193262253_193262429 | 8.59 |
Gm38118 |
predicted gene, 38118 |
504 |
0.62 |
chr7_111004187_111004476 | 8.56 |
Mrvi1 |
MRV integration site 1 |
21870 |
0.15 |
chr2_154765762_154765945 | 8.53 |
Gm14214 |
predicted gene 14214 |
4079 |
0.16 |
chr9_110666013_110666225 | 8.51 |
Ccdc12 |
coiled-coil domain containing 12 |
806 |
0.46 |
chr8_120040971_120041180 | 8.49 |
Gm15684 |
predicted gene 15684 |
4212 |
0.17 |
chr11_51404087_51404246 | 8.47 |
Col23a1 |
collagen, type XXIII, alpha 1 |
114246 |
0.05 |
chr2_24386269_24386618 | 8.47 |
Psd4 |
pleckstrin and Sec7 domain containing 4 |
126 |
0.95 |
chr2_27504248_27504399 | 8.46 |
Brd3 |
bromodomain containing 3 |
3339 |
0.18 |
chr19_3986315_3986684 | 8.45 |
Acy3 |
aspartoacylase (aminoacylase) 3 |
71 |
0.9 |
chr5_96921686_96921899 | 8.40 |
Gm33370 |
predicted gene, 33370 |
383 |
0.52 |
chr14_20478827_20479017 | 8.40 |
Anxa7 |
annexin A7 |
986 |
0.42 |
chr15_76252839_76253010 | 8.40 |
Mir6953 |
microRNA 6953 |
4733 |
0.08 |
chr11_3289074_3290615 | 8.39 |
Patz1 |
POZ (BTB) and AT hook containing zinc finger 1 |
149 |
0.93 |
chr12_17506137_17506851 | 8.39 |
Odc1 |
ornithine decarboxylase, structural 1 |
38300 |
0.11 |
chr8_46845214_46845396 | 8.39 |
Gm45481 |
predicted gene 45481 |
11393 |
0.18 |
chr8_122666824_122667163 | 8.38 |
Cbfa2t3 |
CBFA2/RUNX1 translocation partner 3 |
11079 |
0.1 |
chr12_111516879_111517219 | 8.37 |
Gm40578 |
predicted gene, 40578 |
16209 |
0.1 |
chr2_127314612_127314821 | 8.37 |
Dusp2 |
dual specificity phosphatase 2 |
21443 |
0.11 |
chr4_123928062_123928213 | 8.35 |
Gm12902 |
predicted gene 12902 |
1903 |
0.21 |
chr8_31720101_31720377 | 8.34 |
Gm5117 |
predicted gene 5117 |
19521 |
0.24 |
chr11_100891261_100891855 | 8.34 |
Stat3 |
signal transducer and activator of transcription 3 |
1246 |
0.37 |
chr6_90740671_90740992 | 8.27 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
4144 |
0.21 |
chr11_105366062_105366358 | 8.27 |
Gm11638 |
predicted gene 11638 |
2958 |
0.23 |
chr2_127372220_127372381 | 8.27 |
Adra2b |
adrenergic receptor, alpha 2b |
9014 |
0.14 |
chr13_51736318_51736660 | 8.26 |
Sema4d |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
1726 |
0.37 |
chr1_181230861_181231043 | 8.25 |
A430110L20Rik |
RIKEN cDNA A430110L20 gene |
4876 |
0.16 |
chr11_79003159_79003375 | 8.22 |
Ksr1 |
kinase suppressor of ras 1 |
17143 |
0.16 |
chr8_123978544_123978845 | 8.22 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
4428 |
0.12 |
chr15_97590838_97591009 | 8.19 |
Gm49506 |
predicted gene, 49506 |
32633 |
0.19 |
chr8_108595856_108596007 | 8.14 |
Lncbate1 |
brown adipose tissue enriched long non-coding RNA 1 |
11336 |
0.22 |
chr5_76063456_76063845 | 8.13 |
Gm6051 |
predicted gene 6051 |
2887 |
0.24 |
chr17_32402878_32403059 | 8.13 |
A530088E08Rik |
RIKEN cDNA A530088E08 gene |
38 |
0.9 |
chr7_110877074_110877225 | 8.13 |
Lyve1 |
lymphatic vessel endothelial hyaluronan receptor 1 |
13910 |
0.15 |
chr6_117916728_117917082 | 8.10 |
Hnrnpf |
heterogeneous nuclear ribonucleoprotein F |
76 |
0.91 |
chr15_51918163_51918500 | 8.08 |
Gm48923 |
predicted gene, 48923 |
21244 |
0.15 |
chr1_165717670_165717888 | 8.05 |
Gm37073 |
predicted gene, 37073 |
3777 |
0.12 |
chr9_70840875_70841306 | 8.05 |
Gm3436 |
predicted pseudogene 3436 |
11486 |
0.2 |
chr7_75611639_75612062 | 8.04 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
10 |
0.98 |
chr19_47067510_47068274 | 8.00 |
Taf5 |
TATA-box binding protein associated factor 5 |
146 |
0.92 |
chr11_116534296_116534478 | 8.00 |
Sphk1 |
sphingosine kinase 1 |
227 |
0.83 |
chr19_46639630_46639781 | 7.99 |
Wbp1l |
WW domain binding protein 1 like |
16304 |
0.12 |
chr7_132735252_132735502 | 7.97 |
Fam53b |
family with sequence similarity 53, member B |
41539 |
0.13 |
chr1_91055726_91056053 | 7.94 |
Lrrfip1 |
leucine rich repeat (in FLII) interacting protein 1 |
2303 |
0.31 |
chr14_53766062_53766250 | 7.92 |
Trav15-3 |
T cell receptor alpha variable 15-3 |
870 |
0.53 |
chr7_34313450_34313926 | 7.92 |
4931406P16Rik |
RIKEN cDNA 4931406P16 gene |
137 |
0.94 |
chr9_70841851_70842097 | 7.89 |
Gm3436 |
predicted pseudogene 3436 |
10602 |
0.2 |
chr2_25106317_25106468 | 7.88 |
AL732309.1 |
exonuclease 3'-5' domain containing 3 (EXD3) pseudogene |
9889 |
0.08 |
chr11_120354046_120354234 | 7.88 |
0610009L18Rik |
RIKEN cDNA 0610009L18 gene |
5462 |
0.08 |
chr9_66916250_66916812 | 7.87 |
Rab8b |
RAB8B, member RAS oncogene family |
3156 |
0.21 |
chr9_65826224_65827697 | 7.86 |
Zfp609 |
zinc finger protein 609 |
604 |
0.65 |
chr2_152789626_152789805 | 7.85 |
Gm23802 |
predicted gene, 23802 |
16826 |
0.11 |
chr8_39619900_39620051 | 7.83 |
Msr1 |
macrophage scavenger receptor 1 |
22645 |
0.25 |
chr13_59823073_59823589 | 7.81 |
Gm34961 |
predicted gene, 34961 |
65 |
0.66 |
chr12_26473166_26473360 | 7.74 |
Cmpk2 |
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
667 |
0.64 |
chr1_130740875_130741242 | 7.74 |
Gm28857 |
predicted gene 28857 |
269 |
0.74 |
chr4_137478244_137478657 | 7.74 |
Hspg2 |
perlecan (heparan sulfate proteoglycan 2) |
9647 |
0.14 |
chr1_170709596_170709791 | 7.73 |
Gm23523 |
predicted gene, 23523 |
42130 |
0.12 |
chr7_143005357_143005799 | 7.70 |
Tspan32 |
tetraspanin 32 |
60 |
0.96 |
chr8_120486990_120488549 | 7.70 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
678 |
0.64 |
chr6_120174150_120174339 | 7.69 |
Ninj2 |
ninjurin 2 |
19579 |
0.18 |
chr10_93391391_93391542 | 7.67 |
Gm47344 |
predicted gene, 47344 |
5807 |
0.18 |
chr7_133052918_133053097 | 7.67 |
Ctbp2 |
C-terminal binding protein 2 |
22891 |
0.16 |
chr11_104425117_104425292 | 7.67 |
Gm47315 |
predicted gene, 47315 |
96 |
0.97 |
chr12_32208620_32208788 | 7.67 |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
45 |
0.98 |
chr11_67722541_67722704 | 7.66 |
Rcvrn |
recoverin |
27296 |
0.14 |
chr7_28795913_28796235 | 7.64 |
Rinl |
Ras and Rab interactor-like |
864 |
0.36 |
chr6_48746013_48746293 | 7.62 |
Gimap5 |
GTPase, IMAP family member 5 |
44 |
0.92 |
chr15_79693737_79694025 | 7.62 |
Gtpbp1 |
GTP binding protein 1 |
78 |
0.92 |
chr4_155200896_155201051 | 7.58 |
Ski |
ski sarcoma viral oncogene homolog (avian) |
12677 |
0.17 |
chr13_108297660_108298137 | 7.57 |
Gm8990 |
predicted gene 8990 |
12852 |
0.16 |
chr2_153495771_153496762 | 7.57 |
4930404H24Rik |
RIKEN cDNA 4930404H24 gene |
3476 |
0.22 |
chr8_88302158_88302531 | 7.56 |
Adcy7 |
adenylate cyclase 7 |
1965 |
0.33 |
chrX_144526206_144526357 | 7.55 |
Gm15071 |
predicted gene 15071 |
26954 |
0.17 |
chr17_28829160_28829510 | 7.54 |
Brpf3 |
bromodomain and PHD finger containing, 3 |
1253 |
0.29 |
chr10_77211616_77211790 | 7.52 |
Col18a1 |
collagen, type XVIII, alpha 1 |
45155 |
0.11 |
chr5_147918575_147918726 | 7.51 |
Slc46a3 |
solute carrier family 46, member 3 |
23835 |
0.14 |
chr3_106788080_106788231 | 7.49 |
Cd53 |
CD53 antigen |
1994 |
0.32 |
chr11_106382523_106382839 | 7.49 |
Icam2 |
intercellular adhesion molecule 2 |
100 |
0.95 |
chr2_26139656_26141133 | 7.47 |
Tmem250-ps |
transmembrane protein 250, pseudogene |
127 |
0.93 |
chr11_119677256_119677407 | 7.46 |
Rptor |
regulatory associated protein of MTOR, complex 1 |
21387 |
0.16 |
chr3_137971863_137972060 | 7.45 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
9569 |
0.12 |
chr13_101611411_101611614 | 7.43 |
Gm29341 |
predicted gene 29341 |
5279 |
0.22 |
chr1_43413430_43413581 | 7.42 |
Gm29041 |
predicted gene 29041 |
3921 |
0.25 |
chr6_146221988_146222355 | 7.41 |
Itpr2 |
inositol 1,4,5-triphosphate receptor 2 |
5372 |
0.27 |
chr15_73742747_73743034 | 7.41 |
Ptp4a3 |
protein tyrosine phosphatase 4a3 |
4744 |
0.18 |
chr10_54039973_54040637 | 7.39 |
Gm47917 |
predicted gene, 47917 |
23506 |
0.18 |
chr15_83169975_83170350 | 7.38 |
Cyb5r3 |
cytochrome b5 reductase 3 |
15 |
0.95 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 13.9 | GO:0048769 | sarcomerogenesis(GO:0048769) |
3.8 | 3.8 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
3.6 | 10.7 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
3.4 | 13.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
3.4 | 10.1 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
3.2 | 9.7 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
3.0 | 12.0 | GO:0050904 | diapedesis(GO:0050904) |
3.0 | 6.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
2.9 | 8.7 | GO:0036394 | amylase secretion(GO:0036394) |
2.9 | 8.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
2.7 | 8.0 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
2.6 | 2.6 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
2.6 | 7.9 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
2.6 | 7.8 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
2.5 | 9.9 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
2.5 | 12.4 | GO:0045345 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
2.4 | 2.4 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
2.4 | 12.0 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
2.4 | 7.2 | GO:0003032 | detection of oxygen(GO:0003032) |
2.4 | 7.1 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
2.4 | 7.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
2.3 | 2.3 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
2.3 | 6.8 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
2.2 | 20.0 | GO:0071361 | cellular response to ethanol(GO:0071361) |
2.2 | 4.4 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
2.1 | 6.3 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
2.1 | 6.3 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
2.1 | 6.3 | GO:0002432 | granuloma formation(GO:0002432) |
2.1 | 8.2 | GO:0070836 | caveola assembly(GO:0070836) |
2.0 | 6.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
2.0 | 13.9 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
2.0 | 5.9 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
2.0 | 9.8 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
1.9 | 5.8 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
1.9 | 5.8 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.9 | 7.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.9 | 5.8 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
1.9 | 15.3 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
1.9 | 5.7 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.9 | 5.6 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.8 | 5.5 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
1.8 | 5.5 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
1.8 | 7.2 | GO:0018343 | protein farnesylation(GO:0018343) |
1.8 | 5.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
1.7 | 8.7 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
1.7 | 5.2 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
1.7 | 6.9 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
1.7 | 3.4 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
1.7 | 5.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
1.7 | 6.7 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
1.6 | 8.2 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
1.6 | 4.9 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.6 | 3.2 | GO:0007403 | glial cell fate determination(GO:0007403) |
1.6 | 4.9 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
1.6 | 1.6 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
1.6 | 4.8 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
1.6 | 4.8 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
1.6 | 6.4 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.6 | 7.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.6 | 1.6 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
1.5 | 10.8 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
1.5 | 6.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.5 | 1.5 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.5 | 4.5 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.5 | 4.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.5 | 11.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
1.5 | 3.0 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.5 | 4.5 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
1.5 | 23.3 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
1.5 | 5.8 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
1.4 | 12.8 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
1.4 | 5.7 | GO:0003096 | renal sodium ion transport(GO:0003096) |
1.4 | 11.3 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
1.4 | 1.4 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
1.4 | 16.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.4 | 5.6 | GO:0033483 | gas homeostasis(GO:0033483) |
1.4 | 5.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.4 | 1.4 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.4 | 2.7 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
1.4 | 4.1 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
1.3 | 4.0 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
1.3 | 4.0 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
1.3 | 1.3 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
1.3 | 3.9 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.3 | 5.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
1.3 | 12.9 | GO:0016540 | protein autoprocessing(GO:0016540) |
1.3 | 3.8 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
1.3 | 6.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
1.3 | 7.7 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
1.3 | 19.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
1.3 | 5.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
1.3 | 2.5 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.3 | 3.8 | GO:0090135 | actin filament branching(GO:0090135) |
1.3 | 2.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.3 | 5.0 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.3 | 2.5 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
1.2 | 2.5 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
1.2 | 11.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
1.2 | 1.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
1.2 | 4.9 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
1.2 | 24.5 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
1.2 | 1.2 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
1.2 | 7.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.2 | 2.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.2 | 3.6 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.2 | 4.8 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
1.2 | 1.2 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
1.2 | 3.6 | GO:0003192 | mitral valve formation(GO:0003192) |
1.2 | 3.6 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
1.2 | 7.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
1.2 | 21.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.2 | 2.4 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
1.2 | 3.5 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.2 | 3.5 | GO:0042117 | monocyte activation(GO:0042117) |
1.2 | 2.3 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
1.2 | 2.3 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
1.2 | 1.2 | GO:1900238 | cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
1.2 | 6.9 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
1.2 | 5.8 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
1.1 | 1.1 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
1.1 | 4.5 | GO:0018214 | protein carboxylation(GO:0018214) |
1.1 | 4.5 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
1.1 | 3.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.1 | 10.1 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
1.1 | 4.5 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
1.1 | 1.1 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
1.1 | 10.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
1.1 | 11.1 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
1.1 | 2.2 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
1.1 | 4.4 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
1.1 | 5.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
1.1 | 3.3 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
1.1 | 13.0 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
1.1 | 1.1 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
1.1 | 2.2 | GO:0061198 | fungiform papilla formation(GO:0061198) |
1.1 | 3.2 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.1 | 7.5 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.1 | 4.3 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
1.1 | 2.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.1 | 1.1 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
1.1 | 3.2 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
1.1 | 2.1 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
1.1 | 4.2 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
1.0 | 1.0 | GO:0010965 | regulation of mitotic sister chromatid separation(GO:0010965) |
1.0 | 13.6 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
1.0 | 3.1 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
1.0 | 5.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
1.0 | 4.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.0 | 4.1 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
1.0 | 1.0 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.0 | 6.1 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
1.0 | 4.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
1.0 | 4.1 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
1.0 | 3.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
1.0 | 3.0 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
1.0 | 4.0 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
1.0 | 8.9 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
1.0 | 2.0 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.0 | 2.9 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.0 | 2.0 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
1.0 | 2.9 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
1.0 | 4.9 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.0 | 6.8 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
1.0 | 4.8 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
1.0 | 1.9 | GO:0045472 | response to ether(GO:0045472) |
1.0 | 1.9 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
1.0 | 1.9 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.0 | 8.7 | GO:0097320 | membrane tubulation(GO:0097320) |
1.0 | 2.9 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
1.0 | 3.8 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.0 | 2.9 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.0 | 2.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.9 | 4.7 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.9 | 2.8 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.9 | 4.7 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.9 | 0.9 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.9 | 3.7 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.9 | 12.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.9 | 2.8 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.9 | 2.8 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.9 | 3.7 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.9 | 4.6 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.9 | 3.7 | GO:0051031 | tRNA transport(GO:0051031) |
0.9 | 4.6 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.9 | 11.9 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.9 | 1.8 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.9 | 2.7 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.9 | 1.8 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.9 | 14.6 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.9 | 2.7 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.9 | 6.3 | GO:0006569 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.9 | 2.7 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.9 | 6.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.9 | 2.7 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.9 | 3.6 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.9 | 3.6 | GO:0008228 | opsonization(GO:0008228) |
0.9 | 3.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.9 | 2.7 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.9 | 4.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.9 | 5.3 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.9 | 1.8 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
0.9 | 3.5 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.9 | 2.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.9 | 13.1 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.9 | 4.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.9 | 5.2 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.9 | 2.6 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.9 | 3.4 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.9 | 0.9 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.9 | 1.7 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.9 | 2.6 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.9 | 2.6 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.8 | 2.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.8 | 3.4 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.8 | 2.5 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.8 | 2.5 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.8 | 6.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.8 | 0.8 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.8 | 4.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.8 | 4.1 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.8 | 3.3 | GO:2000416 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
0.8 | 1.6 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.8 | 2.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.8 | 8.9 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.8 | 3.2 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.8 | 1.6 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.8 | 2.4 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.8 | 2.4 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.8 | 2.4 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.8 | 2.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.8 | 3.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.8 | 2.3 | GO:0042938 | dipeptide transport(GO:0042938) |
0.8 | 2.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.8 | 6.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.8 | 2.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.8 | 2.3 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.8 | 0.8 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.8 | 1.5 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.8 | 0.8 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.8 | 32.4 | GO:0070527 | platelet aggregation(GO:0070527) |
0.8 | 2.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.8 | 2.3 | GO:0001555 | oocyte growth(GO:0001555) |
0.8 | 2.3 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.8 | 2.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.8 | 6.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.8 | 13.7 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.8 | 4.6 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.8 | 4.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.7 | 5.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.7 | 0.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.7 | 2.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.7 | 2.9 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.7 | 7.3 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.7 | 4.4 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.7 | 1.4 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.7 | 3.6 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.7 | 0.7 | GO:0009139 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.7 | 2.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.7 | 1.4 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.7 | 0.7 | GO:0032898 | neurotrophin production(GO:0032898) |
0.7 | 2.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.7 | 1.4 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.7 | 5.0 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.7 | 2.8 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.7 | 2.1 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.7 | 7.0 | GO:0018904 | ether metabolic process(GO:0018904) |
0.7 | 2.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.7 | 4.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.7 | 2.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.7 | 1.4 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.7 | 9.8 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.7 | 3.5 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.7 | 5.6 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.7 | 3.5 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.7 | 3.5 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.7 | 6.3 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.7 | 1.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.7 | 2.8 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.7 | 4.8 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.7 | 0.7 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.7 | 8.9 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.7 | 2.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.7 | 0.7 | GO:0035990 | tendon development(GO:0035989) tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.7 | 6.2 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.7 | 0.7 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.7 | 1.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.7 | 4.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.7 | 4.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.7 | 2.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.7 | 2.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.7 | 2.7 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.7 | 1.3 | GO:1904752 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.7 | 1.3 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.7 | 2.0 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.7 | 2.0 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.7 | 7.3 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.7 | 9.9 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.7 | 3.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.7 | 2.6 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.7 | 1.3 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.7 | 1.3 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.6 | 3.2 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.6 | 8.4 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.6 | 0.6 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.6 | 1.9 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.6 | 3.8 | GO:0032782 | bile acid secretion(GO:0032782) |
0.6 | 2.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.6 | 0.6 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.6 | 5.1 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.6 | 1.3 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.6 | 2.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.6 | 1.9 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.6 | 2.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.6 | 2.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.6 | 1.3 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.6 | 5.0 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.6 | 1.9 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.6 | 6.3 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.6 | 3.1 | GO:0001842 | neural fold formation(GO:0001842) |
0.6 | 0.6 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.6 | 10.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.6 | 0.6 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
0.6 | 0.6 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.6 | 1.9 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.6 | 1.9 | GO:0015886 | heme transport(GO:0015886) |
0.6 | 1.9 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.6 | 1.9 | GO:0007296 | vitellogenesis(GO:0007296) |
0.6 | 1.9 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.6 | 1.8 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.6 | 2.5 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.6 | 4.9 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.6 | 0.6 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.6 | 3.0 | GO:0018101 | protein citrullination(GO:0018101) |
0.6 | 0.6 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.6 | 3.0 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.6 | 2.4 | GO:0015705 | iodide transport(GO:0015705) |
0.6 | 3.0 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.6 | 18.0 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.6 | 2.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.6 | 4.2 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.6 | 1.8 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.6 | 18.5 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.6 | 3.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.6 | 1.2 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.6 | 0.6 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.6 | 2.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.6 | 1.8 | GO:0015744 | succinate transport(GO:0015744) |
0.6 | 4.1 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.6 | 2.4 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.6 | 8.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.6 | 2.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.6 | 4.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.6 | 2.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.6 | 0.6 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.6 | 1.2 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.6 | 7.6 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.6 | 2.3 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.6 | 3.5 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.6 | 1.7 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.6 | 2.9 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.6 | 2.3 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.6 | 1.7 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.6 | 3.4 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.6 | 1.1 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.6 | 1.7 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.6 | 1.7 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.6 | 1.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.6 | 0.6 | GO:0043301 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
0.6 | 0.6 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.6 | 0.6 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.6 | 10.5 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.6 | 1.7 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.6 | 0.6 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.5 | 3.8 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.5 | 2.2 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.5 | 1.6 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.5 | 0.5 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.5 | 1.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.5 | 1.6 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.5 | 3.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.5 | 0.5 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.5 | 0.5 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.5 | 3.8 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.5 | 6.4 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.5 | 1.6 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.5 | 2.7 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.5 | 2.1 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.5 | 1.6 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.5 | 1.1 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.5 | 1.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.5 | 5.8 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.5 | 3.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.5 | 0.5 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.5 | 2.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.5 | 1.6 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.5 | 2.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.5 | 1.0 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.5 | 4.7 | GO:0043921 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.5 | 1.6 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.5 | 0.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.5 | 2.6 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.5 | 1.5 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.5 | 2.1 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.5 | 2.6 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.5 | 0.5 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.5 | 0.5 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.5 | 5.6 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.5 | 3.6 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.5 | 1.5 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.5 | 1.0 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.5 | 1.5 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.5 | 1.5 | GO:0000087 | mitotic M phase(GO:0000087) |
0.5 | 2.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.5 | 1.5 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.5 | 5.5 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.5 | 1.5 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.5 | 1.5 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.5 | 0.5 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.5 | 1.5 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.5 | 0.5 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.5 | 1.5 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.5 | 3.0 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.5 | 2.0 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.5 | 12.8 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.5 | 2.5 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.5 | 3.9 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.5 | 2.5 | GO:0015871 | choline transport(GO:0015871) |
0.5 | 1.0 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.5 | 1.5 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.5 | 1.0 | GO:0007494 | midgut development(GO:0007494) |
0.5 | 0.5 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.5 | 1.0 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.5 | 1.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.5 | 2.9 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.5 | 0.5 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.5 | 0.5 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.5 | 3.8 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.5 | 0.5 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.5 | 5.3 | GO:0006903 | vesicle targeting(GO:0006903) |
0.5 | 4.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.5 | 2.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.5 | 1.9 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.5 | 4.3 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.5 | 1.9 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.5 | 2.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.5 | 1.9 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.5 | 4.3 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.5 | 0.9 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.5 | 1.4 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.5 | 2.4 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.5 | 0.9 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.5 | 1.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.5 | 0.5 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.5 | 2.3 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.5 | 2.3 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.5 | 1.9 | GO:0009597 | detection of virus(GO:0009597) |
0.5 | 1.9 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.5 | 0.9 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.5 | 0.9 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.5 | 0.5 | GO:0060903 | regulation of meiosis I(GO:0060631) positive regulation of meiosis I(GO:0060903) |
0.5 | 0.5 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.5 | 0.9 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.5 | 0.9 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.5 | 0.5 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.5 | 4.2 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.5 | 0.5 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.5 | 0.9 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
0.5 | 0.5 | GO:0048478 | replication fork protection(GO:0048478) |
0.5 | 2.7 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.5 | 3.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.5 | 2.3 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.5 | 0.9 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.5 | 1.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.5 | 0.5 | GO:0035973 | aggrephagy(GO:0035973) |
0.5 | 1.8 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.4 | 2.2 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.4 | 1.8 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.4 | 0.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.4 | 0.4 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.4 | 0.9 | GO:0061450 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) |
0.4 | 4.0 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.4 | 6.6 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.4 | 0.4 | GO:0016246 | RNA interference(GO:0016246) |
0.4 | 2.7 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.4 | 4.9 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.4 | 1.8 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.4 | 0.9 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.4 | 0.9 | GO:0006116 | NADH oxidation(GO:0006116) |
0.4 | 2.6 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.4 | 3.1 | GO:0046697 | decidualization(GO:0046697) |
0.4 | 1.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.4 | 0.4 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.4 | 0.9 | GO:1903312 | negative regulation of mRNA metabolic process(GO:1903312) |
0.4 | 1.7 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.4 | 0.9 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.4 | 2.2 | GO:0019081 | viral translation(GO:0019081) |
0.4 | 1.3 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.4 | 1.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.4 | 3.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 0.4 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.4 | 0.9 | GO:0001302 | replicative cell aging(GO:0001302) |
0.4 | 2.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.4 | 0.9 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.4 | 0.9 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.4 | 2.1 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.4 | 5.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.4 | 6.4 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.4 | 2.1 | GO:0050860 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.4 | 2.5 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.4 | 0.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.4 | 0.4 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) |
0.4 | 0.4 | GO:0015819 | lysine transport(GO:0015819) |
0.4 | 3.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.4 | 1.3 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.4 | 1.3 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.4 | 0.4 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.4 | 0.4 | GO:2000977 | negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of pro-B cell differentiation(GO:2000974) regulation of forebrain neuron differentiation(GO:2000977) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
0.4 | 0.8 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.4 | 2.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.4 | 3.3 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.4 | 10.3 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.4 | 1.2 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.4 | 0.8 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.4 | 0.4 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.4 | 6.6 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.4 | 0.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.4 | 1.2 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.4 | 2.5 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.4 | 2.1 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.4 | 0.8 | GO:0045124 | regulation of bone resorption(GO:0045124) |
0.4 | 1.6 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.4 | 4.5 | GO:0002347 | response to tumor cell(GO:0002347) |
0.4 | 0.8 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.4 | 1.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.4 | 1.2 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.4 | 6.5 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.4 | 1.2 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.4 | 1.2 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.4 | 0.8 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.4 | 0.4 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.4 | 12.0 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.4 | 1.6 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.4 | 0.4 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.4 | 0.4 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.4 | 4.0 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.4 | 0.4 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.4 | 9.9 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
0.4 | 2.8 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.4 | 0.8 | GO:0034214 | protein hexamerization(GO:0034214) |
0.4 | 0.4 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.4 | 1.6 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.4 | 2.8 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.4 | 1.6 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.4 | 0.8 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.4 | 1.6 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.4 | 1.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.4 | 1.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.4 | 2.0 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.4 | 1.6 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.4 | 1.2 | GO:0071218 | response to misfolded protein(GO:0051788) cellular response to misfolded protein(GO:0071218) |
0.4 | 1.2 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.4 | 1.9 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.4 | 0.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.4 | 1.9 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.4 | 0.8 | GO:0061511 | centriole elongation(GO:0061511) |
0.4 | 0.4 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
0.4 | 1.5 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.4 | 0.8 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.4 | 1.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.4 | 1.2 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.4 | 5.0 | GO:0001945 | lymph vessel development(GO:0001945) |
0.4 | 1.1 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.4 | 2.7 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.4 | 0.4 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.4 | 0.4 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.4 | 0.4 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.4 | 1.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.4 | 0.4 | GO:0033034 | positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.4 | 1.9 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.4 | 0.8 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.4 | 0.4 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.4 | 1.9 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.4 | 0.8 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.4 | 1.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.4 | 0.8 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.4 | 3.0 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.4 | 0.4 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.4 | 3.8 | GO:0050810 | regulation of steroid biosynthetic process(GO:0050810) |
0.4 | 0.8 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.4 | 1.5 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.4 | 0.4 | GO:0071864 | positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.4 | 0.7 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.4 | 1.1 | GO:0051775 | response to redox state(GO:0051775) |
0.4 | 1.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.4 | 0.4 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.4 | 0.7 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.4 | 0.4 | GO:0002576 | platelet degranulation(GO:0002576) |
0.4 | 0.4 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.4 | 6.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.4 | 1.5 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.4 | 0.4 | GO:0070384 | Harderian gland development(GO:0070384) |
0.4 | 0.7 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.4 | 1.5 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.4 | 1.1 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.4 | 0.4 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.4 | 0.7 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.4 | 1.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.4 | 1.1 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.4 | 1.8 | GO:0016266 | O-glycan processing(GO:0016266) |
0.4 | 1.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.4 | 1.1 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.4 | 0.7 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) positive regulation of phospholipase A2 activity(GO:0032430) |
0.4 | 0.7 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.4 | 1.4 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.4 | 1.4 | GO:2000756 | regulation of peptidyl-lysine acetylation(GO:2000756) |
0.4 | 2.5 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.4 | 1.1 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.4 | 1.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.4 | 1.1 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.4 | 3.9 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.4 | 1.1 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.4 | 1.1 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.4 | 10.9 | GO:0007569 | cell aging(GO:0007569) |
0.4 | 1.1 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.4 | 0.4 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.4 | 1.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 0.7 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.3 | 2.8 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.3 | 1.0 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.3 | 1.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.3 | 7.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.3 | 1.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.3 | 0.7 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.3 | 1.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 1.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.3 | 3.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.3 | 1.7 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.3 | 0.7 | GO:0001805 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.3 | 0.3 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.3 | 1.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.3 | 11.3 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.3 | 4.4 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.3 | 2.0 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.3 | 3.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.3 | 3.7 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.3 | 1.0 | GO:0002215 | defense response to nematode(GO:0002215) |
0.3 | 0.3 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.3 | 0.7 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.3 | 2.4 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.3 | 1.0 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.3 | 3.7 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.3 | 5.7 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 1.0 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.3 | 0.7 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.3 | 3.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.3 | 1.0 | GO:0006056 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.3 | 1.0 | GO:0015747 | urate transport(GO:0015747) |
0.3 | 0.3 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.3 | 0.3 | GO:2000587 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 0.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.3 | 2.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.3 | 0.3 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.3 | 0.3 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.3 | 0.3 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.3 | 0.6 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.3 | 0.6 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.3 | 4.8 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.3 | 0.6 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.3 | 1.6 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.3 | 1.3 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.3 | 1.0 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.3 | 0.3 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.3 | 2.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.3 | 0.6 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.3 | 0.6 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.3 | 1.0 | GO:0061042 | vascular wound healing(GO:0061042) |
0.3 | 4.1 | GO:0042246 | tissue regeneration(GO:0042246) |
0.3 | 0.9 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.3 | 2.5 | GO:0038034 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
0.3 | 1.3 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.3 | 0.3 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.3 | 6.3 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.3 | 0.9 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.3 | 1.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.3 | 0.3 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.3 | 2.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 2.5 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.3 | 0.6 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.3 | 3.4 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.3 | 2.5 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.3 | 0.6 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.3 | 2.5 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.3 | 0.3 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.3 | 0.9 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.3 | 0.6 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.3 | 1.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 0.6 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.3 | 1.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.3 | 0.9 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.3 | 1.5 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.3 | 1.2 | GO:1902713 | regulation of interferon-gamma secretion(GO:1902713) |
0.3 | 0.6 | GO:0072718 | response to cisplatin(GO:0072718) |
0.3 | 0.6 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.3 | 1.2 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.3 | 8.7 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.3 | 1.5 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.3 | 2.1 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.3 | 0.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.3 | 1.2 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.3 | 1.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.3 | 2.4 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.3 | 1.2 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.3 | 2.7 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.3 | 2.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.3 | 0.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.3 | 3.0 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.3 | 1.2 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.3 | 2.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.3 | 0.3 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.3 | 0.9 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.3 | 0.6 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.3 | 0.3 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.3 | 1.5 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 0.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.3 | 0.9 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.3 | 0.9 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.3 | 2.0 | GO:1903053 | regulation of extracellular matrix organization(GO:1903053) |
0.3 | 0.9 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.3 | 3.5 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.3 | 0.6 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.3 | 2.6 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.3 | 0.9 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.3 | 0.3 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.3 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.3 | 1.4 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.3 | 0.6 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.3 | 2.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.3 | 0.3 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.3 | 0.3 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.3 | 0.9 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.3 | 1.4 | GO:0036233 | glycine import(GO:0036233) |
0.3 | 1.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 0.6 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.3 | 1.7 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.3 | 6.5 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.3 | 0.6 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.3 | 4.2 | GO:0043470 | regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) |
0.3 | 0.3 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.3 | 0.3 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.3 | 2.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 2.2 | GO:0030168 | platelet activation(GO:0030168) |
0.3 | 0.6 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.3 | 1.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.3 | 0.8 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.3 | 1.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 0.5 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 0.5 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.3 | 0.8 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.3 | 2.5 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.3 | 1.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 0.8 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.3 | 1.4 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.3 | 2.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.3 | 3.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 3.0 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.3 | 1.6 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.3 | 1.1 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.3 | 0.3 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.3 | 1.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 0.5 | GO:0060525 | prostate glandular acinus development(GO:0060525) |
0.3 | 0.8 | GO:0002760 | positive regulation of antimicrobial humoral response(GO:0002760) |
0.3 | 2.1 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.3 | 1.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.3 | 2.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 0.5 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.3 | 1.3 | GO:0060841 | venous blood vessel development(GO:0060841) |
0.3 | 0.3 | GO:0002861 | regulation of inflammatory response to antigenic stimulus(GO:0002861) |
0.3 | 1.8 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.3 | 1.6 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.3 | 1.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.3 | 0.8 | GO:0060065 | uterus development(GO:0060065) |
0.3 | 1.3 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.3 | 1.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 0.8 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.3 | 0.5 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.3 | 0.5 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.3 | 2.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.3 | 0.3 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.3 | 2.8 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.3 | 4.4 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.3 | 0.8 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.3 | 1.3 | GO:0010470 | regulation of gastrulation(GO:0010470) |
0.3 | 0.3 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.3 | 0.5 | GO:0090009 | primitive streak formation(GO:0090009) |
0.3 | 6.3 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.3 | 0.3 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.3 | 0.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.3 | 1.0 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.3 | 1.8 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.3 | 0.3 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.3 | 2.0 | GO:0002021 | response to dietary excess(GO:0002021) |
0.2 | 0.2 | GO:0036301 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
0.2 | 0.5 | GO:0070266 | necroptotic process(GO:0070266) |
0.2 | 1.0 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.2 | 0.2 | GO:0032353 | negative regulation of hormone biosynthetic process(GO:0032353) |
0.2 | 0.5 | GO:0086029 | Purkinje myocyte action potential(GO:0086017) Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.2 | 0.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 0.2 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.2 | 1.0 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 2.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.2 | 1.0 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.2 | 1.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.2 | 1.0 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.2 | 0.2 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.2 | 1.2 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.2 | 5.1 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.2 | 1.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 2.7 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.2 | 10.0 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.2 | 0.2 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.2 | 0.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.2 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.2 | 3.1 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.2 | 5.8 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 1.0 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 1.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 4.8 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 0.7 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.2 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.2 | 0.5 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 0.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.2 | 1.7 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.2 | 2.4 | GO:0001556 | oocyte maturation(GO:0001556) |
0.2 | 1.4 | GO:0000338 | protein deneddylation(GO:0000338) |
0.2 | 0.5 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.2 | 1.0 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.2 | 0.5 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.2 | 1.4 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 2.4 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 1.9 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.2 | 0.7 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 1.2 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.2 | 0.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 1.4 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.2 | 0.2 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.2 | 0.9 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.2 | 0.5 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.2 | 0.2 | GO:1903431 | positive regulation of cell maturation(GO:1903431) |
0.2 | 4.4 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.2 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 1.6 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.2 | 0.5 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 0.9 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.2 | 0.9 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.2 | 0.7 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.2 | 0.2 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) |
0.2 | 0.9 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.2 | 0.5 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.2 | 0.5 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.2 | 0.2 | GO:0072179 | nephric duct formation(GO:0072179) |
0.2 | 0.2 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.2 | 0.5 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.2 | 0.7 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.2 | 4.3 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 1.4 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.2 | 0.7 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 0.7 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.2 | 0.2 | GO:0061515 | myeloid cell development(GO:0061515) |
0.2 | 2.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 0.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 0.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 | 0.7 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.2 | 0.7 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.2 | 1.1 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
0.2 | 2.0 | GO:0070166 | enamel mineralization(GO:0070166) |
0.2 | 0.7 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.2 | 1.1 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.2 | 0.7 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.2 | 0.4 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.2 | 0.4 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.2 | 0.2 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.2 | 0.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 1.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.4 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.2 | 0.7 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.2 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 1.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.2 | 1.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.7 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.2 | 0.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 0.2 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.2 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 0.6 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.2 | 1.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 0.4 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.2 | 0.9 | GO:0035878 | nail development(GO:0035878) |
0.2 | 0.8 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.2 | 1.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 1.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 1.9 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.2 | 0.2 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.2 | 0.2 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 0.2 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.2 | 0.6 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 1.7 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.2 | 0.8 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 1.0 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 0.6 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 0.2 | GO:0097531 | mast cell migration(GO:0097531) |
0.2 | 4.3 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.2 | 0.4 | GO:0060290 | transdifferentiation(GO:0060290) |
0.2 | 0.8 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.2 | 2.7 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.2 | 0.4 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.2 | 0.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 0.6 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 0.8 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 0.4 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) |
0.2 | 0.2 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.2 | 2.8 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 3.6 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.2 | 0.2 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) |
0.2 | 0.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 0.2 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.2 | 0.8 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.2 | 0.6 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.2 | 2.4 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.2 | 0.2 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.2 | 0.2 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.2 | 3.6 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.2 | 1.0 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.2 | 2.0 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 0.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 2.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.2 | 5.9 | GO:0007041 | lysosomal transport(GO:0007041) |
0.2 | 0.6 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.2 | 0.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.2 | 0.4 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 0.8 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.2 | 0.2 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.2 | 1.4 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.2 | 13.0 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.2 | 1.7 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.2 | 0.2 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.2 | 0.8 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 1.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 0.4 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.2 | 1.0 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 1.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.8 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.6 | GO:0043299 | leukocyte degranulation(GO:0043299) |
0.2 | 0.4 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.2 | 0.2 | GO:0071305 | cellular response to vitamin D(GO:0071305) |
0.2 | 0.4 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.2 | 0.8 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 0.6 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.2 | 0.9 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 1.1 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 0.4 | GO:0097050 | type B pancreatic cell apoptotic process(GO:0097050) |
0.2 | 0.2 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.2 | 0.4 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.2 | 0.9 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 1.3 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 0.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.9 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 1.5 | GO:0048821 | erythrocyte development(GO:0048821) |
0.2 | 0.4 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 1.5 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.2 | 0.9 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.2 | 0.5 | GO:0033280 | response to vitamin D(GO:0033280) |
0.2 | 2.7 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 0.2 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.2 | 0.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 0.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.2 | 0.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.5 | GO:0015846 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 0.4 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 0.2 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.2 | 0.2 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 0.4 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.2 | 0.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 0.4 | GO:0006573 | valine metabolic process(GO:0006573) |
0.2 | 3.0 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.2 | 0.7 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.2 | 4.6 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.2 | 0.7 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 12.8 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.2 | 1.4 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 1.0 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.2 | 0.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 0.7 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 0.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.2 | 2.9 | GO:0060323 | head morphogenesis(GO:0060323) |
0.2 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 0.9 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.2 | 0.3 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.2 | 0.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 0.5 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 1.2 | GO:0034030 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.2 | 0.5 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.2 | 0.3 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.2 | 0.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 0.5 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.2 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.2 | 0.2 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.2 | 1.0 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.2 | 0.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.2 | 0.8 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 0.3 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.2 | 0.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.8 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.2 | 0.2 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.2 | 0.3 | GO:0051953 | negative regulation of amine transport(GO:0051953) |
0.2 | 1.1 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.2 | 0.5 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.2 | 1.3 | GO:0032400 | melanosome localization(GO:0032400) |
0.2 | 0.8 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.2 | 0.2 | GO:0071616 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.2 | 1.6 | GO:0017144 | drug metabolic process(GO:0017144) |
0.2 | 0.2 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.2 | 0.3 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.2 | 0.2 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.2 | 0.2 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 1.3 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
0.2 | 0.3 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.2 | 2.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 0.6 | GO:0010224 | response to UV-B(GO:0010224) |
0.2 | 0.2 | GO:0046005 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.2 | 0.5 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.2 | 1.7 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.2 | 1.2 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.2 | 0.5 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.2 | 0.2 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.2 | 1.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 0.3 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.2 | 3.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 0.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 1.4 | GO:0035094 | response to nicotine(GO:0035094) |
0.2 | 0.3 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.2 | 0.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.2 | 1.2 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.2 | 0.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.2 | 1.8 | GO:0044804 | nucleophagy(GO:0044804) |
0.2 | 0.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 0.3 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.2 | 0.2 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 2.1 | GO:0007602 | phototransduction(GO:0007602) |
0.2 | 1.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 0.8 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.2 | 1.2 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 0.4 | GO:0072757 | cellular response to camptothecin(GO:0072757) |
0.1 | 0.1 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.1 | 3.4 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.4 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.1 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.3 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.1 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 0.1 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.1 | 0.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 1.3 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 1.8 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.3 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.1 | 0.7 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.3 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.1 | 0.9 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.1 | 0.1 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
0.1 | 0.9 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 1.4 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 4.3 | GO:0050658 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) |
0.1 | 0.6 | GO:0050779 | RNA destabilization(GO:0050779) |
0.1 | 0.7 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.6 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.1 | 0.1 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 0.1 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.1 | 3.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 1.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.4 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.8 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.1 | 2.2 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.8 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.1 | 0.3 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.1 | 0.4 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 1.1 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.1 | 0.3 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.3 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
0.1 | 0.1 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.1 | 0.5 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.1 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 0.1 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 0.9 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.1 | GO:0072172 | ureteric bud formation(GO:0060676) mesonephric tubule formation(GO:0072172) |
0.1 | 1.1 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 | 0.9 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.1 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.1 | 0.1 | GO:0071295 | cellular response to vitamin(GO:0071295) |
0.1 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.7 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.4 | GO:0072663 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 2.0 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.1 | 0.9 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.1 | 0.8 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.7 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.5 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.3 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.4 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.4 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.5 | GO:0034367 | macromolecular complex remodeling(GO:0034367) protein-lipid complex remodeling(GO:0034368) plasma lipoprotein particle remodeling(GO:0034369) |
0.1 | 0.3 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.1 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 0.3 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.6 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.1 | 0.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.1 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.8 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.1 | 0.9 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.2 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.9 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.1 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.1 | 0.5 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.1 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.1 | 0.4 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.6 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.1 | 0.2 | GO:0090026 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.5 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 2.1 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.1 | 1.0 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.2 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.6 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.8 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 0.8 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.2 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.1 | 0.1 | GO:0019230 | proprioception(GO:0019230) |
0.1 | 0.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 1.3 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.1 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.1 | 0.8 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.5 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.5 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 0.5 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 0.1 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.1 | 0.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 1.4 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.1 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.1 | 0.3 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.1 | 0.2 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.1 | 0.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.9 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.1 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.1 | 0.1 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.1 | 0.3 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 1.9 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.5 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.9 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.2 | GO:0003203 | endocardial cushion morphogenesis(GO:0003203) |
0.1 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 3.3 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.4 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.1 | 3.1 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.1 | 0.2 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.4 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.2 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 0.6 | GO:0034105 | positive regulation of tissue remodeling(GO:0034105) |
0.1 | 0.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 1.9 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 2.6 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.2 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.4 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.3 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.1 | 0.2 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.1 | 0.5 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.6 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) |
0.1 | 0.6 | GO:0070633 | transepithelial transport(GO:0070633) |
0.1 | 1.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 4.5 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.1 | 0.1 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 1.2 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.1 | 2.5 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 1.0 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.5 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 0.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.1 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.1 | 1.2 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.1 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) |
0.1 | 0.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.2 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 2.1 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.1 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 2.6 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.1 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.1 | 0.5 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.1 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.3 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.5 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.2 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.1 | 0.1 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 0.9 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.1 | 0.2 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.1 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.1 | 1.0 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.3 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.9 | GO:0071385 | cellular response to glucocorticoid stimulus(GO:0071385) |
0.1 | 0.2 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.1 | 0.4 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.1 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.1 | 0.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 1.7 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.1 | 4.4 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 0.1 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.1 | 0.1 | GO:0032602 | chemokine production(GO:0032602) |
0.1 | 0.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.1 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 1.4 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 0.1 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.1 | 0.7 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 0.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 1.3 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.9 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 0.4 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.1 | GO:0002931 | response to ischemia(GO:0002931) |
0.1 | 0.1 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.1 | 1.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.1 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.1 | 0.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 0.1 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 0.7 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.1 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.2 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.1 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.1 | GO:0010823 | negative regulation of mitochondrion organization(GO:0010823) |
0.1 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.1 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.1 | 0.4 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.1 | 0.1 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.1 | 0.2 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 0.1 | GO:0051352 | negative regulation of ligase activity(GO:0051352) |
0.1 | 0.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.1 | GO:0040031 | snRNA modification(GO:0040031) |
0.1 | 0.2 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 1.1 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.2 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.2 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 0.6 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.2 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) |
0.1 | 0.4 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.1 | 0.4 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.1 | 0.2 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
0.1 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.5 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 0.2 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.2 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.1 | 0.1 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.2 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.1 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.1 | 0.1 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.1 | 0.3 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.1 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.1 | 0.6 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.1 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.1 | 0.5 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.6 | GO:1903320 | regulation of protein modification by small protein conjugation or removal(GO:1903320) |
0.1 | 0.8 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 1.0 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.3 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.4 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.2 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.1 | 1.1 | GO:0003281 | ventricular septum development(GO:0003281) |
0.1 | 0.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.1 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.1 | 0.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.2 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 0.5 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.2 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.1 | 0.3 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.1 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
0.1 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.1 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.1 | 0.1 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.1 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.1 | GO:0070673 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.1 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.3 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.1 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 0.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.1 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.1 | 0.4 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.1 | GO:0014824 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.1 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.2 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 0.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.1 | GO:0051304 | chromosome separation(GO:0051304) |
0.1 | 0.6 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.1 | 0.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.2 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.1 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.1 | 0.1 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.1 | 0.4 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.2 | GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
0.1 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.4 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.1 | 0.4 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.5 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 0.1 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.1 | 0.3 | GO:0007595 | lactation(GO:0007595) |
0.1 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.2 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.1 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.1 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.1 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.5 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 0.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 1.0 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.5 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.2 | GO:0002673 | regulation of acute inflammatory response(GO:0002673) |
0.1 | 1.3 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.1 | GO:0000237 | leptotene(GO:0000237) |
0.1 | 4.2 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.1 | 0.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.1 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.1 | 0.1 | GO:0001893 | maternal placenta development(GO:0001893) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 1.4 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.1 | 0.5 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 0.6 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.1 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 0.1 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.1 | 0.1 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.1 | 0.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.1 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.1 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.1 | 0.7 | GO:1903322 | positive regulation of protein modification by small protein conjugation or removal(GO:1903322) |
0.1 | 0.9 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.1 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.1 | 0.3 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.1 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.1 | 0.1 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.1 | 0.1 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.1 | 1.2 | GO:0030814 | regulation of cAMP metabolic process(GO:0030814) |
0.1 | 0.3 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.3 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.1 | GO:2000826 | regulation of heart morphogenesis(GO:2000826) |
0.1 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.2 | GO:0097459 | iron ion import into cell(GO:0097459) |
0.1 | 0.7 | GO:0048747 | muscle fiber development(GO:0048747) |
0.0 | 0.3 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.0 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.0 | 0.0 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.0 | 0.1 | GO:0060433 | bronchus development(GO:0060433) |
0.0 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.1 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.0 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.0 | 0.0 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.0 | 0.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.3 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.0 | 0.1 | GO:1903580 | positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of ATP metabolic process(GO:1903580) |
0.0 | 0.0 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.0 | 0.0 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.0 | 0.0 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.0 | 0.0 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.0 | 0.1 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.0 | 0.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.0 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.0 | 0.0 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 2.7 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.5 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 0.9 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.4 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.5 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.8 | GO:0007338 | single fertilization(GO:0007338) |
0.0 | 0.2 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.0 | 0.9 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.1 | GO:0042711 | maternal behavior(GO:0042711) |
0.0 | 0.4 | GO:0043487 | regulation of RNA stability(GO:0043487) |
0.0 | 0.1 | GO:0032369 | negative regulation of lipid transport(GO:0032369) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.0 | GO:0046135 | pyrimidine ribonucleoside metabolic process(GO:0046131) pyrimidine nucleoside catabolic process(GO:0046135) |
0.0 | 0.9 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.0 | GO:0070198 | protein localization to chromosome, telomeric region(GO:0070198) |
0.0 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.0 | 0.0 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.0 | 0.0 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.2 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.3 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.0 | 0.2 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.1 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.0 | 1.6 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 1.2 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.0 | 0.2 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.2 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.0 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.0 | 0.1 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 0.0 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.0 | 0.0 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.0 | 1.4 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 3.0 | GO:0032496 | response to lipopolysaccharide(GO:0032496) |
0.0 | 0.2 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.0 | GO:0021626 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
0.0 | 0.0 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.0 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.0 | 0.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 1.3 | GO:0098792 | xenophagy(GO:0098792) |
0.0 | 0.0 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.0 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0034502 | protein localization to chromosome(GO:0034502) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.4 | GO:0042107 | cytokine metabolic process(GO:0042107) |
0.0 | 0.0 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.0 | 0.0 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.1 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.0 | 0.9 | GO:0016573 | histone acetylation(GO:0016573) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.1 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.2 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.2 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.0 | 0.0 | GO:0033032 | regulation of myeloid cell apoptotic process(GO:0033032) |
0.0 | 0.1 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.0 | 0.0 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.1 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.0 | 0.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 0.0 | GO:1902930 | regulation of alcohol biosynthetic process(GO:1902930) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.0 | 0.0 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.0 | 0.0 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.0 | 0.0 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.0 | 0.4 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.0 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.0 | GO:1901658 | glycosyl compound catabolic process(GO:1901658) |
0.0 | 2.0 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.1 | GO:0061371 | determination of heart left/right asymmetry(GO:0061371) |
0.0 | 0.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.1 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.9 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.1 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.0 | 0.0 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
0.0 | 0.2 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.0 | 0.3 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.2 | GO:0055007 | cardiac muscle cell differentiation(GO:0055007) |
0.0 | 0.5 | GO:0051297 | centrosome organization(GO:0051297) |
0.0 | 0.0 | GO:0086073 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.0 | 0.0 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 0.0 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 0.0 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.0 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.0 | 3.3 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 0.0 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.1 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.0 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) |
0.0 | 0.0 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.0 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.0 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.0 | 0.0 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.0 | GO:0002704 | negative regulation of leukocyte mediated immunity(GO:0002704) |
0.0 | 0.0 | GO:0032660 | regulation of interleukin-17 production(GO:0032660) |
0.0 | 0.0 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.0 | 0.0 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.0 | 0.0 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 8.3 | GO:0097443 | sorting endosome(GO:0097443) |
2.6 | 10.4 | GO:0030689 | Noc complex(GO:0030689) |
2.6 | 7.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
2.5 | 7.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
2.5 | 9.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
2.1 | 6.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
2.1 | 6.2 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.9 | 9.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.9 | 5.7 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.9 | 5.6 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
1.7 | 3.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
1.7 | 16.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.7 | 3.3 | GO:0098827 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
1.6 | 9.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.6 | 9.7 | GO:0030056 | hemidesmosome(GO:0030056) |
1.6 | 3.1 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.5 | 6.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.5 | 20.4 | GO:0001891 | phagocytic cup(GO:0001891) |
1.4 | 4.3 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.4 | 5.7 | GO:0072487 | MSL complex(GO:0072487) |
1.4 | 5.7 | GO:0000322 | storage vacuole(GO:0000322) |
1.4 | 30.8 | GO:0008305 | integrin complex(GO:0008305) |
1.4 | 8.4 | GO:0042629 | mast cell granule(GO:0042629) |
1.4 | 4.2 | GO:0035061 | interchromatin granule(GO:0035061) |
1.4 | 8.3 | GO:0001739 | sex chromatin(GO:0001739) |
1.4 | 4.1 | GO:0005745 | m-AAA complex(GO:0005745) |
1.3 | 6.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.3 | 4.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
1.3 | 5.1 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
1.2 | 3.7 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.2 | 12.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.2 | 3.6 | GO:0097441 | basilar dendrite(GO:0097441) |
1.2 | 8.4 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.2 | 4.7 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.1 | 8.8 | GO:0070578 | RISC-loading complex(GO:0070578) |
1.1 | 4.3 | GO:0042583 | chromaffin granule(GO:0042583) |
1.1 | 8.5 | GO:0005861 | troponin complex(GO:0005861) |
1.0 | 6.1 | GO:0005796 | Golgi lumen(GO:0005796) |
1.0 | 1.0 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
1.0 | 4.8 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.9 | 6.6 | GO:0031931 | TORC1 complex(GO:0031931) |
0.9 | 6.6 | GO:0035102 | PRC1 complex(GO:0035102) |
0.9 | 2.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.9 | 9.0 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.9 | 3.6 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.9 | 2.7 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.9 | 0.9 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.9 | 3.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.9 | 6.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.9 | 3.5 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.8 | 1.7 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.8 | 6.7 | GO:0001939 | female pronucleus(GO:0001939) |
0.8 | 3.3 | GO:0000125 | PCAF complex(GO:0000125) |
0.8 | 8.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.8 | 4.8 | GO:0005818 | aster(GO:0005818) |
0.8 | 3.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.8 | 7.0 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.8 | 3.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.8 | 6.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.8 | 4.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.7 | 31.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.7 | 2.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.7 | 2.2 | GO:0097413 | Lewy body(GO:0097413) |
0.7 | 8.1 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.7 | 2.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.7 | 10.9 | GO:0002102 | podosome(GO:0002102) |
0.7 | 3.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.7 | 2.9 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.7 | 2.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.7 | 2.1 | GO:0043293 | apoptosome(GO:0043293) |
0.7 | 3.6 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.7 | 6.4 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.7 | 2.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.7 | 4.2 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.7 | 2.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.7 | 2.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.7 | 3.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.7 | 2.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.7 | 4.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.7 | 3.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.7 | 5.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.7 | 2.7 | GO:0000938 | GARP complex(GO:0000938) |
0.7 | 12.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.7 | 12.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.7 | 4.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.7 | 10.5 | GO:0005682 | U5 snRNP(GO:0005682) |
0.6 | 2.6 | GO:1990130 | Iml1 complex(GO:1990130) |
0.6 | 13.3 | GO:0090544 | BAF-type complex(GO:0090544) |
0.6 | 2.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.6 | 3.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.6 | 5.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.6 | 5.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.6 | 1.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.6 | 1.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.6 | 42.7 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.6 | 1.8 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.6 | 1.2 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.6 | 5.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.6 | 2.3 | GO:0005642 | annulate lamellae(GO:0005642) |
0.6 | 5.8 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.6 | 13.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.6 | 1.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.6 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.6 | 1.7 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.6 | 1.7 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.5 | 1.6 | GO:0005687 | U4 snRNP(GO:0005687) |
0.5 | 0.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.5 | 3.7 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.5 | 2.1 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.5 | 20.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.5 | 1.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.5 | 5.7 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.5 | 3.1 | GO:0051286 | cell tip(GO:0051286) |
0.5 | 12.3 | GO:0097228 | sperm principal piece(GO:0097228) |
0.5 | 2.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.5 | 3.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.5 | 4.1 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.5 | 2.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.5 | 1.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.5 | 1.0 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.5 | 7.5 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.5 | 4.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.5 | 3.9 | GO:0001650 | fibrillar center(GO:0001650) |
0.5 | 8.4 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.5 | 2.4 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.5 | 2.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.5 | 1.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.5 | 1.4 | GO:0097422 | tubular endosome(GO:0097422) |
0.5 | 2.4 | GO:0097255 | R2TP complex(GO:0097255) |
0.5 | 1.4 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.5 | 1.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.5 | 1.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 1.9 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.5 | 2.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.5 | 5.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.5 | 11.6 | GO:0001772 | immunological synapse(GO:0001772) |
0.5 | 11.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.5 | 4.6 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.5 | 3.2 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.5 | 1.8 | GO:0033263 | CORVET complex(GO:0033263) |
0.5 | 1.8 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.5 | 4.6 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.5 | 2.7 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.5 | 1.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.4 | 2.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.4 | 3.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 1.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.4 | 3.0 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.4 | 3.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.4 | 1.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.4 | 1.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.4 | 3.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.4 | 1.7 | GO:1990246 | uniplex complex(GO:1990246) |
0.4 | 0.8 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.4 | 6.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.4 | 2.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.4 | 1.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.4 | 0.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.4 | 3.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.4 | 2.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 0.4 | GO:1990423 | RZZ complex(GO:1990423) |
0.4 | 3.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.4 | 3.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.4 | 1.6 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.4 | 1.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.4 | 1.6 | GO:0032021 | NELF complex(GO:0032021) |
0.4 | 1.2 | GO:0005827 | polar microtubule(GO:0005827) |
0.4 | 5.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.4 | 0.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.4 | 3.9 | GO:0045120 | pronucleus(GO:0045120) |
0.4 | 3.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.4 | 1.6 | GO:0098536 | deuterosome(GO:0098536) |
0.4 | 7.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.4 | 1.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.4 | 7.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.4 | 7.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.4 | 24.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.4 | 2.3 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.4 | 1.5 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.4 | 1.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.4 | 12.4 | GO:0016592 | mediator complex(GO:0016592) |
0.4 | 2.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.4 | 11.2 | GO:0016459 | myosin complex(GO:0016459) |
0.4 | 5.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.4 | 4.8 | GO:0016460 | myosin II complex(GO:0016460) |
0.4 | 3.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.4 | 1.5 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.4 | 9.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.4 | 0.4 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.4 | 1.8 | GO:0005638 | lamin filament(GO:0005638) |
0.4 | 20.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.4 | 22.5 | GO:0001726 | ruffle(GO:0001726) |
0.4 | 9.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.4 | 4.3 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.4 | 8.9 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.4 | 3.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.3 | 30.7 | GO:0030027 | lamellipodium(GO:0030027) |
0.3 | 4.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 1.7 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.3 | 2.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.3 | 10.0 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 1.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.3 | 24.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.3 | 1.7 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.3 | 2.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.3 | 1.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.3 | 8.5 | GO:0031901 | early endosome membrane(GO:0031901) |
0.3 | 0.7 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 0.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.3 | 1.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.3 | 2.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.3 | 0.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.3 | 34.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.3 | 30.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 0.7 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 7.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 16.3 | GO:0005811 | lipid particle(GO:0005811) |
0.3 | 0.6 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 0.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.3 | 1.2 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 2.8 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 0.9 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 3.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 1.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.3 | 1.8 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 0.9 | GO:0030891 | VCB complex(GO:0030891) |
0.3 | 4.2 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.3 | 3.0 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 1.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.3 | 1.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.3 | 0.9 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 1.5 | GO:0034709 | methylosome(GO:0034709) |
0.3 | 0.9 | GO:0033270 | paranode region of axon(GO:0033270) |
0.3 | 12.9 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.3 | 1.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.3 | 28.3 | GO:0005769 | early endosome(GO:0005769) |
0.3 | 0.6 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 2.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.3 | 1.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.3 | 17.6 | GO:0005814 | centriole(GO:0005814) |
0.3 | 0.6 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.3 | 5.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.3 | 2.8 | GO:0036379 | myofilament(GO:0036379) |
0.3 | 0.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 0.8 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 0.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.3 | 2.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.3 | 15.9 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.3 | 1.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.3 | 3.0 | GO:0031011 | Ino80 complex(GO:0031011) |
0.3 | 2.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.3 | 1.6 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 1.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.3 | 1.8 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.3 | 1.3 | GO:0001652 | granular component(GO:0001652) |
0.3 | 12.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.3 | 1.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.3 | 2.3 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.3 | 1.0 | GO:0043203 | axon hillock(GO:0043203) |
0.3 | 0.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.3 | 1.3 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.2 | 0.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.2 | 15.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 1.5 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 1.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 0.9 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.2 | 4.6 | GO:0000786 | nucleosome(GO:0000786) |
0.2 | 1.2 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 0.9 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 6.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 0.7 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 0.7 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.2 | 0.9 | GO:0038201 | TOR complex(GO:0038201) |
0.2 | 2.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 0.9 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 16.6 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.2 | 4.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 0.7 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 1.1 | GO:0097346 | INO80-type complex(GO:0097346) |
0.2 | 0.7 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 0.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.4 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 1.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 3.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 1.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 1.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 1.4 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.2 | 0.6 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 0.8 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.2 | 1.8 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 0.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 0.8 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 0.2 | GO:0042827 | platelet dense granule(GO:0042827) |
0.2 | 0.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 1.4 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.2 | 0.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 0.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 0.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 0.2 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) XPC complex(GO:0071942) |
0.2 | 21.3 | GO:0031965 | nuclear membrane(GO:0031965) |
0.2 | 0.8 | GO:0036128 | CatSper complex(GO:0036128) |
0.2 | 2.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 0.4 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 1.5 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 0.5 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.2 | 3.1 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.2 | 1.3 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 0.5 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 24.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 6.6 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 4.2 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 1.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.2 | 0.5 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 1.6 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 2.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 0.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 2.7 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.2 | 4.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 0.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 2.5 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 0.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 22.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 3.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 1.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 187.7 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 0.5 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 0.6 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 0.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.2 | 0.2 | GO:1990696 | USH2 complex(GO:1990696) |
0.2 | 0.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 6.4 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.2 | 0.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 5.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 22.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 1.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 1.6 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 6.2 | GO:0031252 | cell leading edge(GO:0031252) |
0.1 | 0.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.7 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 0.4 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 0.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.3 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 2.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.4 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 1.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 0.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.3 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 1.2 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 1.8 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 1.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.1 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 88.4 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 1.0 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 5.0 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.1 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.1 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
0.1 | 1.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.6 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 3.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 2.2 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.3 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 3.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 2.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 23.6 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 1.7 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 1.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.2 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 0.4 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.3 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.1 | 4.5 | GO:0005903 | brush border(GO:0005903) |
0.1 | 2.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.2 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 2.8 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.5 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.7 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 1.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 16.0 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.3 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 1.1 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 1.1 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 0.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 1.7 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.4 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 4.3 | GO:0044431 | Golgi apparatus part(GO:0044431) |
0.1 | 40.5 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.9 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 5.8 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.7 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 1.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 7.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.1 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 5.3 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.0 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.1 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.0 | GO:1990462 | omegasome(GO:1990462) |
0.0 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 31.0 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.2 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 2.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 1.0 | GO:0097223 | sperm part(GO:0097223) |
0.0 | 1.5 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.0 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.0 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 14.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
3.0 | 17.9 | GO:0001727 | lipid kinase activity(GO:0001727) |
2.9 | 8.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
2.7 | 10.8 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
2.7 | 8.1 | GO:0035877 | death effector domain binding(GO:0035877) |
2.5 | 9.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
2.4 | 9.8 | GO:0051425 | PTB domain binding(GO:0051425) |
2.1 | 15.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
2.0 | 12.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
2.0 | 8.0 | GO:0004046 | aminoacylase activity(GO:0004046) |
2.0 | 9.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
2.0 | 9.8 | GO:0043559 | insulin binding(GO:0043559) |
1.9 | 7.7 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.9 | 13.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.9 | 15.4 | GO:0051400 | BH domain binding(GO:0051400) |
1.9 | 9.5 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
1.9 | 7.5 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
1.9 | 5.6 | GO:0009041 | uridylate kinase activity(GO:0009041) |
1.8 | 7.1 | GO:0031014 | troponin T binding(GO:0031014) |
1.8 | 1.8 | GO:0016748 | succinyltransferase activity(GO:0016748) |
1.7 | 6.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.7 | 6.9 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.7 | 10.2 | GO:0008199 | ferric iron binding(GO:0008199) |
1.7 | 5.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.7 | 8.3 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.6 | 6.5 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
1.6 | 6.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.6 | 6.4 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
1.6 | 9.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.6 | 6.3 | GO:0042731 | PH domain binding(GO:0042731) |
1.5 | 12.4 | GO:1990405 | protein antigen binding(GO:1990405) |
1.5 | 7.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.5 | 10.4 | GO:0030957 | Tat protein binding(GO:0030957) |
1.5 | 4.5 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
1.4 | 4.3 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
1.4 | 11.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.4 | 5.5 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
1.4 | 5.5 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.4 | 4.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.3 | 13.5 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
1.3 | 13.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
1.3 | 11.8 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
1.3 | 2.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.2 | 3.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.2 | 6.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.2 | 1.2 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
1.2 | 4.8 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.2 | 6.0 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
1.2 | 3.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.2 | 5.9 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
1.1 | 6.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.1 | 3.4 | GO:0050692 | DBD domain binding(GO:0050692) |
1.1 | 4.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.1 | 9.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.1 | 1.1 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
1.1 | 6.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
1.1 | 5.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.1 | 3.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.1 | 3.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.1 | 20.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
1.1 | 2.1 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
1.1 | 5.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.0 | 2.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
1.0 | 4.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.0 | 3.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
1.0 | 5.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.0 | 2.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.0 | 1.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.0 | 5.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
1.0 | 19.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
1.0 | 2.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.0 | 2.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
1.0 | 1.9 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.9 | 8.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.9 | 2.8 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.9 | 4.7 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.9 | 6.5 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.9 | 4.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.9 | 4.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.9 | 0.9 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.9 | 4.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.9 | 2.7 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.9 | 2.7 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.9 | 0.9 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.9 | 3.6 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.9 | 7.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.9 | 4.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.9 | 5.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.9 | 0.9 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.9 | 3.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.9 | 2.6 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.8 | 5.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.8 | 10.1 | GO:0010181 | FMN binding(GO:0010181) |
0.8 | 3.3 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.8 | 10.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.8 | 3.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.8 | 0.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.8 | 3.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.8 | 2.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.8 | 10.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.8 | 2.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.8 | 0.8 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.8 | 5.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.8 | 3.9 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.8 | 10.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.8 | 6.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.8 | 3.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.8 | 4.6 | GO:0004064 | arylesterase activity(GO:0004064) |
0.8 | 3.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.8 | 22.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.7 | 6.7 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.7 | 3.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.7 | 4.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.7 | 3.7 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.7 | 2.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.7 | 2.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.7 | 4.5 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.7 | 2.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.7 | 3.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.7 | 2.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.7 | 6.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.7 | 3.7 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.7 | 2.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.7 | 2.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.7 | 1.4 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.7 | 4.3 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.7 | 5.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.7 | 12.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.7 | 5.0 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.7 | 2.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.7 | 2.8 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.7 | 10.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.7 | 2.1 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.7 | 3.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.7 | 4.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.7 | 13.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.7 | 4.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.7 | 12.8 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.7 | 2.0 | GO:0055100 | adiponectin binding(GO:0055100) |
0.7 | 3.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.7 | 2.0 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.7 | 5.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.7 | 2.6 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.6 | 6.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.6 | 1.9 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.6 | 1.9 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.6 | 17.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.6 | 1.9 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.6 | 1.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.6 | 0.6 | GO:0019961 | interferon binding(GO:0019961) |
0.6 | 1.2 | GO:0030172 | troponin C binding(GO:0030172) |
0.6 | 4.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.6 | 4.9 | GO:0031996 | thioesterase binding(GO:0031996) |
0.6 | 5.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.6 | 5.5 | GO:0031432 | titin binding(GO:0031432) |
0.6 | 3.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.6 | 10.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.6 | 4.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.6 | 1.8 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.6 | 3.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.6 | 1.8 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.6 | 1.8 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.6 | 8.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.6 | 1.7 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.6 | 38.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.6 | 2.9 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.6 | 4.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.6 | 5.1 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.6 | 1.7 | GO:0051379 | epinephrine binding(GO:0051379) |
0.6 | 1.7 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.6 | 3.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.6 | 2.8 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.6 | 1.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.5 | 1.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.5 | 1.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.5 | 1.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.5 | 6.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.5 | 2.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.5 | 0.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.5 | 1.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.5 | 1.6 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.5 | 1.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.5 | 1.1 | GO:0004096 | catalase activity(GO:0004096) |
0.5 | 4.2 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.5 | 1.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.5 | 2.6 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.5 | 4.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.5 | 9.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.5 | 12.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.5 | 1.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 13.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.5 | 19.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.5 | 1.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.5 | 1.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.5 | 0.5 | GO:0016530 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
0.5 | 4.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.5 | 0.5 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.5 | 2.0 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.5 | 2.5 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.5 | 2.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.5 | 2.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.5 | 1.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.5 | 12.2 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.5 | 4.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.5 | 1.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.5 | 3.9 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.5 | 2.4 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.5 | 1.9 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.5 | 1.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.5 | 4.8 | GO:0004568 | chitinase activity(GO:0004568) |
0.5 | 1.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.5 | 9.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.5 | 2.9 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.5 | 13.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.5 | 16.6 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.5 | 0.9 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.5 | 3.8 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.5 | 4.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.5 | 1.4 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.5 | 2.8 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.5 | 3.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.5 | 0.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.5 | 1.9 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.5 | 5.6 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.5 | 0.9 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.5 | 4.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.5 | 4.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.5 | 1.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.5 | 1.8 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.4 | 11.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.4 | 2.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.4 | 1.3 | GO:0002046 | opsin binding(GO:0002046) |
0.4 | 1.8 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.4 | 2.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.4 | 12.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.4 | 3.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.4 | 4.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 3.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.4 | 1.7 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.4 | 11.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.4 | 1.3 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.4 | 0.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.4 | 2.6 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.4 | 2.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.4 | 2.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.4 | 1.7 | GO:0005534 | galactose binding(GO:0005534) |
0.4 | 2.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 3.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 7.2 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.4 | 34.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.4 | 2.9 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.4 | 1.7 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.4 | 32.7 | GO:0005178 | integrin binding(GO:0005178) |
0.4 | 2.9 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.4 | 2.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.4 | 2.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.4 | 4.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.4 | 6.9 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.4 | 0.4 | GO:0008061 | chitin binding(GO:0008061) |
0.4 | 2.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 0.4 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.4 | 0.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.4 | 4.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.4 | 2.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.4 | 3.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.4 | 2.0 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.4 | 1.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.4 | 1.2 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.4 | 1.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.4 | 0.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.4 | 1.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.4 | 1.2 | GO:1990188 | euchromatin binding(GO:1990188) |
0.4 | 2.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.4 | 7.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.4 | 1.6 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.4 | 11.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.4 | 3.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 1.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 0.4 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.4 | 3.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.4 | 12.6 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.4 | 1.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.4 | 3.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.4 | 0.4 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 3.4 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.4 | 1.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 2.3 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.4 | 2.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 0.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.4 | 1.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.4 | 0.4 | GO:0038132 | neuregulin binding(GO:0038132) |
0.4 | 0.7 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.4 | 3.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.4 | 1.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.4 | 2.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 2.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.4 | 3.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.4 | 2.2 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.4 | 0.7 | GO:0031013 | troponin I binding(GO:0031013) |
0.4 | 1.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.4 | 8.8 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.4 | 1.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.4 | 2.5 | GO:0070402 | NADPH binding(GO:0070402) |
0.4 | 0.7 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.4 | 1.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.4 | 1.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.4 | 0.7 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.4 | 3.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.4 | 0.4 | GO:0034618 | arginine binding(GO:0034618) |
0.4 | 3.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.4 | 7.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.4 | 62.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.4 | 1.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.4 | 2.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 2.5 | GO:0046790 | virion binding(GO:0046790) |
0.4 | 1.1 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.4 | 0.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 3.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 3.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.3 | 1.7 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.3 | 1.0 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.3 | 25.1 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.3 | 0.7 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.3 | 2.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.3 | 0.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 1.4 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.3 | 2.4 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.3 | 2.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.3 | 4.0 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 0.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 3.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 1.3 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.3 | 8.6 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.3 | 17.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.3 | 2.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 3.6 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.3 | 2.0 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.3 | 3.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 0.3 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.3 | 1.6 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.3 | 1.6 | GO:0017040 | ceramidase activity(GO:0017040) |
0.3 | 0.6 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.3 | 1.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.3 | 1.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 4.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.3 | 1.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 33.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.3 | 2.5 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 6.0 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.3 | 1.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 1.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.3 | 1.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 0.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.3 | 0.6 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.3 | 1.8 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.3 | 3.1 | GO:0005542 | folic acid binding(GO:0005542) |
0.3 | 0.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.3 | 0.9 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.3 | 1.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.3 | 0.9 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 0.3 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.3 | 16.1 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.3 | 3.0 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.3 | 3.0 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.3 | 1.5 | GO:0000150 | recombinase activity(GO:0000150) |
0.3 | 1.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.3 | 1.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.3 | 2.1 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.3 | 2.4 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.3 | 0.3 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.3 | 0.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.3 | 1.5 | GO:0070061 | fructose binding(GO:0070061) |
0.3 | 2.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 0.9 | GO:0019002 | GMP binding(GO:0019002) |
0.3 | 0.9 | GO:0031433 | telethonin binding(GO:0031433) |
0.3 | 0.6 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 2.9 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 0.6 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.3 | 0.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.3 | 0.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 0.6 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 0.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.3 | 1.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.3 | 1.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.3 | 3.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.3 | 0.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.3 | 5.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 1.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 0.8 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 0.5 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.3 | 6.8 | GO:0000049 | tRNA binding(GO:0000049) |
0.3 | 0.5 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.3 | 2.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 0.8 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.3 | 4.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.3 | 0.8 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.3 | 5.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 1.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.3 | 3.5 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.3 | 0.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.3 | 6.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.3 | 0.8 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.3 | 0.8 | GO:0008142 | oxysterol binding(GO:0008142) |
0.3 | 0.8 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 0.3 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.3 | 2.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 4.1 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.3 | 6.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 1.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.3 | 0.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.3 | 35.8 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.3 | 4.0 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.3 | 0.3 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.3 | 1.0 | GO:0015925 | galactosidase activity(GO:0015925) |
0.3 | 1.0 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 2.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 1.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 0.5 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 1.5 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.2 | 1.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 7.3 | GO:0043621 | protein self-association(GO:0043621) |
0.2 | 5.3 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 0.7 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 2.4 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 4.8 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.2 | 0.5 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.2 | 1.4 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 1.9 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.2 | 0.9 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.2 | 3.6 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.2 | 7.6 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.2 | 1.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 1.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 0.9 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 2.8 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 4.6 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 2.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 1.8 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 2.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 0.7 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.2 | 0.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 1.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 4.3 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 1.6 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.2 | 1.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 0.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 1.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.4 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 0.7 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 2.4 | GO:0019213 | deacetylase activity(GO:0019213) |
0.2 | 11.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 0.7 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 1.3 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.2 | 0.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 0.4 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.9 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 0.6 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 0.4 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.2 | 9.9 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.2 | 0.9 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 0.9 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 0.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 2.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 3.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.2 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.2 | 0.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 0.6 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.2 | 0.6 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 0.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 0.6 | GO:0035473 | lipase binding(GO:0035473) |
0.2 | 1.1 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 7.8 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.2 | 3.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 5.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 2.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 0.6 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.2 | 0.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 0.2 | GO:0016208 | AMP binding(GO:0016208) |
0.2 | 5.8 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 1.9 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.2 | 0.6 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.2 | 0.6 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 1.0 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.2 | 1.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 0.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 0.4 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.2 | 1.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 2.6 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 1.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 9.9 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 2.1 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 1.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 1.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 3.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 0.4 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 0.6 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 1.0 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 1.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 0.6 | GO:0019862 | IgA binding(GO:0019862) |
0.2 | 0.9 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 0.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 0.2 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.2 | 0.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 0.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 0.9 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 8.5 | GO:0060090 | binding, bridging(GO:0060090) |
0.2 | 0.2 | GO:0045182 | translation regulator activity(GO:0045182) |
0.2 | 0.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) thiol oxidase activity(GO:0016972) |
0.2 | 0.4 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 0.4 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 0.7 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.2 | 2.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 0.2 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.2 | 2.0 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.2 | 2.7 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 0.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 0.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 8.6 | GO:0035326 | enhancer binding(GO:0035326) |
0.2 | 0.7 | GO:0002054 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
0.2 | 2.1 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.2 | 1.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.2 | 1.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 2.6 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.2 | 0.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 0.2 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 1.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.5 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 0.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 5.1 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 4.2 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.2 | 0.2 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
0.2 | 0.8 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.2 | 0.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 1.5 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.2 | 1.0 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 2.0 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.2 | 4.4 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 41.3 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.2 | 0.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 0.7 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 4.6 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.2 | 0.8 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.2 | 0.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 0.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 2.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.2 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 2.5 | GO:0044105 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.2 | 1.4 | GO:0036222 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.2 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 0.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 1.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 0.9 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 0.3 | GO:0015928 | fucosidase activity(GO:0015928) |
0.2 | 0.6 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.2 | 0.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 14.8 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 2.5 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 1.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 1.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 0.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 0.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.4 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 1.0 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 3.2 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 1.0 | GO:0018450 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 1.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.4 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.3 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 7.9 | GO:0051020 | GTPase binding(GO:0051020) |
0.1 | 4.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.6 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 1.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 1.0 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 3.2 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.5 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.1 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.1 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.3 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.4 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 1.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 1.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.6 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.1 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 0.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.4 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 7.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.9 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.4 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 1.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 22.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.2 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.9 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 3.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 3.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.1 | 1.0 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.1 | 0.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.7 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 0.5 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.6 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.6 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.2 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.1 | 0.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.1 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.1 | 1.2 | GO:0016229 | steroid dehydrogenase activity(GO:0016229) |
0.1 | 0.2 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.7 | GO:0034951 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 0.2 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 0.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 1.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.1 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.5 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.2 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 2.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.4 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 2.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.3 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 0.2 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.1 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 19.3 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 1.0 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 1.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 1.8 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 1.4 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.9 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.5 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 5.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.8 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 1.0 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 0.4 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.8 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.6 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.9 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.1 | GO:0070492 | disaccharide binding(GO:0048030) oligosaccharide binding(GO:0070492) |
0.1 | 0.1 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) amidine-lyase activity(GO:0016842) |
0.1 | 0.6 | GO:0019209 | kinase activator activity(GO:0019209) |
0.1 | 1.9 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 3.0 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.3 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 0.1 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.1 | 0.1 | GO:0070990 | snRNP binding(GO:0070990) |
0.1 | 0.5 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.7 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 0.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 0.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 0.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 5.6 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 0.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.5 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 2.8 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.2 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.1 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 0.2 | GO:0016723 | cupric reductase activity(GO:0008823) oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.3 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.0 | 0.2 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.2 | GO:0034548 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.3 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 1.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.8 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.0 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.1 | GO:0018568 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.0 | 0.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.4 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 3.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.3 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.4 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.1 | GO:2001070 | starch binding(GO:2001070) |
0.0 | 1.0 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.0 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.0 | 0.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.1 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.0 | 0.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.6 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.6 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.1 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 20.2 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.0 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.2 | GO:0016405 | CoA-ligase activity(GO:0016405) |
0.0 | 0.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.0 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 1.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.8 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.0 | 1.4 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.8 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.0 | 0.2 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 2.0 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.0 | 0.1 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.0 | 0.1 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 0.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.0 | GO:0046977 | TAP binding(GO:0046977) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.0 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.0 | 1.1 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 1.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.0 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.0 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.0 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 2.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.7 | 3.4 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
1.6 | 4.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.4 | 39.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.3 | 32.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.2 | 8.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.2 | 18.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.1 | 28.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
1.1 | 49.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.0 | 15.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.0 | 35.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.9 | 1.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.9 | 21.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.8 | 10.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.8 | 13.9 | PID IGF1 PATHWAY | IGF1 pathway |
0.8 | 10.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.8 | 6.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.8 | 14.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.7 | 12.7 | PID MYC PATHWAY | C-MYC pathway |
0.7 | 19.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.7 | 8.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.7 | 38.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.7 | 9.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.7 | 27.0 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.7 | 9.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.7 | 25.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.6 | 8.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.6 | 4.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.6 | 4.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.6 | 3.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.6 | 3.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.6 | 44.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.6 | 11.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.6 | 5.9 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.6 | 8.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.6 | 4.0 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.6 | 13.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.5 | 1.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.5 | 22.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.5 | 21.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.5 | 5.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.5 | 5.0 | PID BCR 5PATHWAY | BCR signaling pathway |
0.5 | 3.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.5 | 7.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.5 | 5.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.5 | 1.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.5 | 7.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.4 | 4.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 4.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.4 | 12.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.4 | 2.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.4 | 18.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.4 | 11.9 | PID PLK1 PATHWAY | PLK1 signaling events |
0.4 | 1.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.4 | 10.7 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.4 | 16.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.4 | 6.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.4 | 0.8 | ST STAT3 PATHWAY | STAT3 Pathway |
0.4 | 0.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 2.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.4 | 4.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 10.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 1.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 2.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 3.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 3.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 7.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 1.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 7.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.3 | 7.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 2.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 1.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 2.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 8.8 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 4.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 2.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 2.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.3 | 0.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 1.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 1.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 1.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 6.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 3.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 1.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.2 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 4.3 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 6.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 2.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 1.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 3.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 1.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 3.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 5.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 2.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 21.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 0.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 1.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 2.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 5.9 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 1.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 2.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 20.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 4.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.4 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 1.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.4 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 1.4 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.0 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 0.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 1.8 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
1.4 | 16.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
1.3 | 13.0 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
1.3 | 26.8 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
1.2 | 12.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.2 | 37.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
1.2 | 12.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.2 | 7.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.1 | 8.9 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
1.0 | 9.0 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
1.0 | 8.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.9 | 10.2 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.9 | 22.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.9 | 13.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.9 | 33.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.9 | 20.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.9 | 3.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.8 | 11.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.8 | 3.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.8 | 4.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.8 | 5.6 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.8 | 16.6 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.8 | 12.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.8 | 8.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.8 | 7.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.8 | 20.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.7 | 3.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.7 | 7.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.7 | 19.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.7 | 16.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.7 | 10.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.7 | 5.7 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.7 | 6.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.7 | 3.4 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.7 | 4.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.7 | 10.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.7 | 5.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.7 | 8.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.7 | 15.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.7 | 0.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.6 | 11.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.6 | 0.6 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.6 | 4.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.6 | 8.5 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.6 | 3.0 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.6 | 7.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.6 | 0.6 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.6 | 9.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.6 | 49.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.6 | 22.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.6 | 4.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.6 | 9.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.6 | 5.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.5 | 33.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.5 | 3.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.5 | 7.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.5 | 45.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.5 | 14.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.5 | 7.4 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.5 | 45.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.5 | 6.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.5 | 26.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.5 | 1.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.5 | 14.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.5 | 5.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.5 | 9.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.5 | 4.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.5 | 0.5 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.4 | 0.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.4 | 0.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 2.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 2.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.4 | 14.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.4 | 3.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.4 | 10.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.4 | 5.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.4 | 7.8 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.4 | 3.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.4 | 3.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.4 | 2.3 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.4 | 2.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.4 | 0.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 3.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.4 | 3.3 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.4 | 8.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.4 | 1.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 7.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.4 | 1.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.4 | 0.7 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.4 | 1.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 4.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 3.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.3 | 14.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.3 | 1.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 0.7 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.3 | 7.7 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.3 | 4.7 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.3 | 4.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 4.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 1.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.3 | 28.4 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.3 | 0.6 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.3 | 0.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.3 | 4.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.3 | 2.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 5.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 1.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.3 | 1.2 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.3 | 1.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.3 | 2.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 0.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.3 | 16.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 2.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.3 | 0.8 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.3 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.3 | 1.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 5.2 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.3 | 5.6 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.3 | 1.6 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 3.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 5.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.3 | 1.8 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.3 | 13.8 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 2.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 1.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 0.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 1.5 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 0.5 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 1.5 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.2 | 4.1 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.2 | 0.5 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.2 | 2.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 1.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 6.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 2.5 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.2 | 2.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 1.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 0.9 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.2 | 4.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 1.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 1.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 1.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.2 | 0.6 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.2 | 2.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 9.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 0.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 0.6 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 3.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 1.2 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.2 | 1.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 2.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 2.4 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.2 | 4.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 1.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 2.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 0.2 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.2 | 1.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 0.4 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 2.3 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.2 | 1.2 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.2 | 2.1 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 27.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 1.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 5.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 0.3 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.2 | 3.0 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.2 | 4.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 0.2 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.2 | 0.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 1.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 2.2 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.2 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 3.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 2.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.8 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.8 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 0.4 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 0.4 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.1 | 0.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 0.5 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 0.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 1.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 4.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 0.4 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 0.6 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 1.7 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 1.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 2.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 0.8 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 0.4 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 0.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.9 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 2.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 0.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.9 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.1 | 0.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.5 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 1.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 18.8 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.1 | 0.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 0.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.4 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 0.5 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.1 | 0.1 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
0.1 | 0.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.4 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 3.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.2 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 1.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.0 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.6 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.5 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.1 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 0.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.0 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |